Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Telitacicept”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06656962
What this trial is testing

The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

Who this might be right for
Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
Renmin Hospital of Wuhan University 15
Not applicableLooking for participantsNCT06654596
What this trial is testing

Efficacy and Safety of Telitacicept in IgAN

Who this might be right for
IgA Nephropathy (IgAN)Kidney DiseasesTelitacicept+1 more
Ruijin Hospital 118
Large-scale testing (Phase 3)Looking for participantsNCT06125405
What this trial is testing

Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome in ChildrenTelitacicept
The Children's Hospital of Zhejiang University School of Medicine 20
Not applicableUnknownNCT05588830
What this trial is testing

The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study

Who this might be right for
Lupus NephritisBelimumabTelitacicept
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07111338
What this trial is testing

Telitacicept for PGNMID: A Single-Arm Study

Who this might be right for
Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
Peking University First Hospital 10
Not applicableLooking for participantsNCT06979271
What this trial is testing

Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis

Who this might be right for
TelitaciceptTreatment ComplianceRheumatoid Arthritis
Zhejiang Provincial People's Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06614985
What this trial is testing

The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Renmin Hospital of Wuhan University 172
Post-approval studies (Phase 4)UnknownNCT05666336
What this trial is testing

Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
Fen Li 30
Not applicableStudy completedNCT07031674
What this trial is testing

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

Who this might be right for
Lupus NephritisBelimumab
Yipeng Liu 56
Testing effectiveness (Phase 2)Looking for participantsNCT06375005
What this trial is testing

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, Zhejiang University, School of Medicine 38
Testing effectiveness (Phase 2)Ended earlyNCT05078710
What this trial is testing

Telitacicept in Primary APS Patients

Who this might be right for
Anti Phospholipid Syndrome
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07796516
What this trial is testing

Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis

Who this might be right for
Difficult-to-treat Rheumatoid ArthritisRheumatoid Arthritis
Peking University People's Hospital 420
Not applicableLooking for participantsNCT07491016
What this trial is testing

Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

Who this might be right for
TelitaciceptTreatment ComplianceRheumatoid Arthritis
Zhejiang Provincial People's Hospital 30
Not applicableNot Yet RecruitingNCT06827587
What this trial is testing

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Who this might be right for
Myasthenia GravisAutoimmune DiseasesNeuromuscular Diseases
First Affiliated Hospital of Wenzhou Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07340463
What this trial is testing

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Nanjing University School of Medicine 50
Not applicableActive Not RecruitingNCT07053137
What this trial is testing

A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

Who this might be right for
Systemic Lupus ErythematosusTelitaciceptBelimumab+1 more
Yipeng Liu 180
Testing effectiveness (Phase 2)Looking for participantsNCT05680480
What this trial is testing

Telitacicept in Lupus Nephritis

Who this might be right for
Lupus Nephritis
RemeGen Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT05673993
What this trial is testing

Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome

Who this might be right for
Primary Sjogren's Syndrome
RemeGen Co., Ltd. 381
Not applicableNot Yet RecruitingNCT07069972
What this trial is testing

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
Yipeng Liu 180
Post-approval studies (Phase 4)Looking for participantsNCT05965284
What this trial is testing

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

Who this might be right for
ANCA-associated VasculitisMaintenance Therapy
Chinese SLE Treatment And Research Group 40
Next Page